Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 1 - 10 of about 79   

Articles published

ARNA 6.16 -0.18 (-2.84%)
price chart
Arena Pharmaceuticals' Belviq Sales Dip - Why?
Belviq, the anti-obesity drug from Arena Pharmaceuticals (ARNA), saw sales fall over 10% last week according to industry tracking services IMS Health and Symphony Health.
Special News Alert: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Incyte ...  Market News Call
Related articles »  
Healthcare Watch List: Arena Pharmaceuticals (NASDAQ:ARNA), Abbott ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) reported that Eisai Inc. has launched a national television advertising campaign for BELVIQ� (lorcaserin HCl), an FDA-approved prescription treatment for chronic weight management.
Related articles »  
Stocks Alert: Arena Pharmaceuticals, Inc. (NASDAQ: ARNA), Idera ...
Lakeway, NY - (MARKET NEWS CALL) - 4/23/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Worth Watching Stocks: Inovio Pharmaceuticals, (INO), Arena Pharmaceuticals ...  Techsonian (press release)
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): TV Ads For Belviq Launched
Dallas, Texas 04/17/2014 (ustradevoice) - One of the main reasons, analysts and pundits say, why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has not had success with its FDA-approved weight management drug known as Belviq, is lack of awareness.
Small Cap Recent Insider Selling: Arena Pharmaceuticals (NASDAQ:ARNA ...  Tech News
Biotech recent insider selling: Arena Pharmaceuticals (NASDAQ:ARNA ...  Gaining Green
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): The Future Is Encouraging
That being the case, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) seems to have come to the realization that unless it takes proactive steps to expand the market share of its anti-obesity drug Belviq, it might as well miss out on a great opportunity.
Big Movers: MannKind Corporation (NASDAQ:MNKD), Arena Pharmaceuticals ...
Lakeway, NY - (MARKET NEWS CALL) - 4/22/2014� Specialpennystockalert.com, an investment community with a special focus on updating investors with recent news on the U.S.
Related articles »  
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Expecting Sales to hit $150M this ...
Dallas, Texas 03/31/2014 (ustradevoice) - Biopharmaceutical Company, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), expects majority of its revenue for the year to come from its flagship drug, Belviq.
Stocks to Keep Your Eyes on: Arena Pharmaceuticals, Inc. (NASDAQ:ARNA ...
Las Vegas, NV - April 23, 2014 - (TechSonian) - Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), declared that Eisai Inc. has started a national television advertising campaign for BELVIQ, an FDA-approved prescription treatment for chronic weight ...
Related articles »  
Coverage of Biotech Equities -- Research on Arena Pharma, Celgene, PDL ...
Free technical research on ARNA, CELG, PDLI and HEB can be downloaded upon signing up at: http://www.investor-edge.com/905-register On Monday, shares in Arena Pharmaceuticals Inc. gained 2.57% to close the day at $6.38. The stock recorded a ...
Related articles »  
Hot Biotech Stocks: Arena Pharmaceuticals (NASDAQ:ARNA), Ariad ...
One of the main reasons, analysts and pundits say, why Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has not had success with its FDA-approved weight management drug known as Belviq, is lack of awareness.
Related articles »